Cancer immunotherapy: predicting outcomes

Today's monoclonal antibody treatments benefit some patients but can be harmful to others; the search for reliable predictive biomarkers is on

Genome editing: Talking to patients

With genome editing hitting the headlines, patients may have questions about its applications. Here’s our concise guide for health professionals

Genomics in 2018: 3 key predictions

We asked three wise men and women to tell us what they think 2018 will bring for genomics in healthcare

What is NIPT?

Non-invasive prenatal testing will be rolled out in the NHS next year. But how does it work? And what are the benefits?

New precision medicine approaches to breast cancer

Patients in London and Manchester the first to benefit from methods to better predict, prevent and treat breast cancer, with aims to roll out nationally
Genomics lab

Delivering the genomic dream

Ahead of her appearance at Expo 2017, Chief Scientific Officer Sue Hill outlines the exciting work she is leading on genomics across the NHS

Gene therapy hope for sickle cell anaemia patients

A teenager with severe sickle cell anaemia has been successfully treated with a pioneering gene therapy approach

Fighting adverse drug reactions

When it comes to therapeutic treatments, one size doesn’t fit all. Could genomic tests be the key to minimising the harmful side effects of drugs?

How genome editing could enter mainstream medicine

Forget designer babies and novelty pets. The potential for genome editing to improve the health of the general population is already emerging

Genomics in government policy

How do we bring exciting research, exceptional medicine and public opinion to routine clinical practice?

Point-of-care testing in genomics

Rapid advances in technology are revolutionising healthcare. How viable is portable DNA testing?

Reference genome: defining human difference

In order to make assertions about genomic variation and health, scientists rely on the ‘reference genome’ – but how definitive is it?